Filter your results
- 2
- 1
- 3
- 3
- 2
- 1
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC StudyPLoS ONE, 2015, 10 (12), pp.e0145105. ⟨10.1371/journal.pone.0145105⟩
Journal articles
hal-01257993v1
|
||
Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infectionJournal of Hepatology, 2014, 61 (4), pp.770 - 776. ⟨10.1016/j.jhep.2014.05.040⟩
Journal articles
pasteur-01384212v1
|
|||
Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapyLiver International, 2015, 35 (7), pp.1833 - 1844. ⟨10.1111/liv.12759⟩
Journal articles
istex
pasteur-01380846v1
|